Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-001481

Director sold 3,750 shares at $76.08 ($285,300)

  • Director acquired 9,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Waddill William D. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-01 Grant or award : show line 1 in the form +9,000 34,000 D
2021-01-04 Sale : show line 2 in the form −3,750 $76.08 $285,300 30,250 D
Open-market sales · 3,750 sh · avg $76.08 · $285,300
Loading xslF345X03/doc4.xml…